Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tofacitinib 5 MG [Xeljanz]
DRUG
3 trials
Sponsors
Shinshu University
, University of Oxford
, Jing Liang
Conditions
Clinically Amyopathic Dermatomyisitis(CAMD)
Depression
Inflammation
Rheumatoid Arthritis
Phase 1
Tofacitinib in Depression (TIDE)
Terminated
NCT04141904
University of Oxford
Depression, Inflammation
Start: 2020-02-10
End: 2022-05-23
Updated: 2022-08-09
Phase 2
Examination of Efficacy and Safety of Baricitinib in RA Patients
NCT03755466
Shinshu University
Rheumatoid Arthritis
Start: 2018-11-21
End: 2025-11-20
Target: 90
Updated: 2021-09-21
Unknown Phase
Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung Disease
NCT04613219
Jing Liang
Clinically Amyopathic Dermatomyisitis(CAMD)
Start: 2020-10-01
End: 2023-04-30
Target: 80
Updated: 2020-11-03